Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,470 shares at $562.00 ($3.1M) on 2020-05-07, disclosed to the SEC on 2020-05-07.
Open-market sale of $3.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $555.77 | 123 | $68K | 2.2% |
| 2 | $555.77 | 3,538 | $2.0M | 64.4% |
| 3 | $562.00 | 1,809 | $1.0M | 33.3% |
| Total | $557.83 avg | 5,470 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |